Şunu aradınız:: carboxy (İngilizce - Maltaca)

carboxy methyl cellulose
Ċelluloża tal-carboxy methyl

sodium carboxy methyl cellulose
Ċelluloża tal-carboxy methyl tas-sodju

sodium carboxy methyl cellulose, cellulose gum
karbossimetilċelluloża tas-sodju, gomma taċ-ċelluloża

carboxy- dabrafenib is excreted in bile and urine.
carboxy-dabrafenib jitneħħa mis-sistema biljari u l-awrina.

enzymatically hydrolysed carboxy methyl cellulose, enzymatically hydrolysed cellulose gum
karbossimetilċelluloża idrolizzata b'mod enżimatiku, gomma taċ-ċelluloża idrolizzata b'mod enżimatiku

a decrease of 16% in auc was noted for carboxy-dabrafenib.
Ġie nnotat tnaqqis ta’ 16 % fl-auc għal carboxy-dabrafenib.

carboxy-terminated polybutadiene (including carboxyl-terminated polybutadiene) (ctpb);
polibutadien bir-radikali terminali tal-karbossi (inkluż ilpolibutadien bir-radikali terminali tal-karbossili) (ctpb);

these carboxy-terminal fragments are thought to play a role in the regulation of parathyroid hormone activity.
dawn il-frammenti carboxy-terminali huma maħsuba li għandhom rwol fir-regolazzjoni ta’ l-attività ta’ l-ormon tal-paratirojde.

carboxy-dabrafenib can be decarboxylated via a non-enzymatic process to form desmethyl-dabrafenib.
carboxy-dabrafenib jista’ jitneħħielu d-dijossidu tal-karbonju, permezz ta’ proċess mhux enzimatiku biex jiġi ffurmat desmethyl-dabrafenib.

the active metabolite is further metabolised in the liver to its carboxy, carboxy-n-desisopropyl, and
il- metabolit attiv ikompli jkun metaboliżżat ġol- fwied u jifforma l- metaboliti carboxy, carboxy- n- desisopropyl u n- desisopropyl bl- involviment ta ’ cypd6 u cyp3a4.

circulating carboxy-terminal fragments are filtered by the kidney, but are subsequently broken to even smaller fragments during tubular reuptake.
il-frammenti carboxy-terminali jiġu ffiltrati mill- kliewi, iżda suċċessivament jiġu mkissra fi frammenti saħansitra iżgħar matul ir-riassorbiment tubulari.

the metabolism of dabrafenib is primarily mediated by cyp2c8 and cyp3a4 to form hydroxy- dabrafenib, which is further oxidised via cyp3a4 to form carboxy-dabrafenib.
il-metaboliżmu ta’ dabrafenib huwa medjat primarjament minn cyp2c8 u cyp3a4 biex jifforma hydroxy-dabrafenib, li huwa ossidizzat ulterjorment permezz ta’ cyp3a4 biex jiġi ffurmat carboxy- dabrafenib.

the fragments derived from the amino-terminus are further degraded within the cell while the fragments derived from the carboxy-terminius are released back into the blood and cleared by the kidney.
il-frammenti derivati mill-amino-terminus ikomplu jiġu degradati fiċ-ċellola filwaqt li l-frammenti derivati mill-carboxy-terminius jerġgħu jiġu rilaxxati

the major metabolites found in all species were the 5-hydroxy- and 5-carboxy- metabolites and the oxalyl- metabolite.
il-metaboliti ewlenin li jinsabu f’kull speċi kienu l-metaboliti 5-hydroxy- u 5-carboxy u l-metabolit oxalyl.

copolymer of methyl acrylate with ethylene and a monomer containing a non-terminal carboxy group as a substituent, containing by weight 50 % or more of methyl acrylate, whether or not mixed with silicon dioxide
kopolimeru ta’ methyl acrylate bl-ethylene u monomeru li fih non-terminal karbossiliku group bħala sostitut, li fih, f’piż, 50 % jew aktar methyl acrylate, anki jekk imħallat mas-dijossidu tas-silikon

two metabolites – most probably resulting from hepatic metabolism (major enzyme is cyp2c9) – were identified both in urine and faeces: the hydroxy derivative and the carboxy derivative.
Żewġ metaboliti – wisq probabbli rriżultaw minn metaboliżmu epatika (l-enżima prinċipali hija cyp2c9) – kienu identifikati kemm fl-awrina kif ukoll fil-feċi: id-derivat ta’ hydroxyl u d-derivat ta’ carboxy.